TrialsgrambetaRCTs are beautiful

RE-ALIGN

2013

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

In 252 patients with a mechanical aortic or mitral valve, dabigatran led to more thromboembolic events and major bleeding compared with warfarin.

Result

Trough plasma dabigatran level over 12 weeks (thromboembolism/valve thrombosis/bleeding were secondary)
Absolute difference
5 points

The absolute difference is derived from the event rates.

Also reported: Major bleed 4 % vs 2 %. Trial halted for harm.

Original publication
Subtopic
Anticoagulation
Design
Phase II, open-label, dose-validation; stopped early
Relevance
Important: one of several pillars.
Source
Eikelboom JW, et al. N Engl J Med. 2013;369(13):1206-1214.doi 10.1056/NEJMoa1300615

Discussion & critique

Confirms: NOACs are not interchangeable with VKAs for mechanical valves. Warfarin remains the only validated agent; INR targets depend on valve type & position.

Discussed in podcasts